The Next New Thing | GenomeWeb

The Next New Thing

Since it burst onto the scientific scene in 2012, CRISPR/Cas9 has been "hailed as dramatically easier, cheaper, and more versatile than previous technologies" for altering genomes, says Nature News.

But it's not perfect, and researchers are already looking for alternatives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.